Graft-vs-Host Disease

Explore clinical trials studying Graft-vs-Host Disease. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Graft-vs-Host Disease trial results

Not Yet Recruiting

Emerging Indications for Hyperbaric Oxygen Treatment

NCT07240649

Conditions: Acute COVID-19, Anastomosis, Leaking, Arterial Occlusive Diseases, +137 more
Locations: Not specified

View Trial Details

Completed

Vulvovaginal Graft Versus Host Disease (VV-GVHD) in Women Who Underwent Transplantation Before and After Menarche

NCT01512498

Conditions: Graft vs Host Disease, Graft-vs-Host Disease, Immune System Diseases
Locations: Pediatric Hematology Oncology Department, Rambam Hospital Haifa, Israel

Hadassah University Hospital Jerusalem, Israel

View Trial Details

Completed

Cognitive Function and Patient-Reported Quality of Life Outcomes Investigation in Patients Taking Vorinostat

NCT02409134

Conditions: Graft vs Host Disease, Graft-vs-Host Disease, Hematologic Diseases, +6 more
Locations: University of Michigan Health System Ann Arbor, Michigan, United States

View Trial Details

Completed

Keratinocyte Growth Factor to Prevent Acute GVHD

NCT00031148

Conditions: Graft vs Host Disease, Graft-vs-Host Disease, Immune System Diseases
Locations: University of Michigan Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Completed

Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD)

NCT01318330

Conditions: Graft vs Host Disease, Graft-vs-Host Disease, Immune System Diseases
Locations: Inha University Hospital Incheon, South Korea

Seoul National University Hospital Seoul, South Korea

Seoul St. Mary's Hospital Seoul, South Korea

Asan Medical Center Seoul, South Korea

View Trial Details

Completed

A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-

NCT00189748

Conditions: Bone Marrow Transplantation, Graft Versus Host Disease, Graft vs Host Disease, +3 more
Locations: Chubu Region, Japan

Hokkaido Region, Japan

Kanto Region, Japan

Kyusyu Region, Japan

View Trial Details

Completed

A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients

NCT00189761

Conditions: Bone Marrow Transplantation, Graft Versus Host Disease, Graft vs Host Disease, +3 more
Locations: Chubu Region, Japan

Hokkaido Region, Japan

Kanto Region, Japan

Kyusyu Region, Japan

View Trial Details

Graft-vs-Host Disease

Graft-vs-Host Disease trial results

Emerging Indications for Hyperbaric Oxygen Treatment

Vulvovaginal Graft Versus Host Disease (VV-GVHD) in Women Who Underwent Transplantation Before and After Menarche

Cognitive Function and Patient-Reported Quality of Life Outcomes Investigation in Patients Taking Vorinostat

Keratinocyte Growth Factor to Prevent Acute GVHD

Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD)

A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-

A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients

Related conditions